Position in JNJ
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$65,848,324
-$22,845,018 QoQ
Shares Held
259,276
-28.5% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.70%
of 13F equity value
Holder Rank
#390
of 4,676 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Vest Financial, LLC holds $177,449,874 across 8 Drug Manufacturers - General names. JNJ ranks #2 (37.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
268,319 | $67,519,792 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
259,276 | $65,848,324 | |
| 3 | LLY |
ELI LILLY & Co
|
14,258 | $17,101,473 | |
| 4 | MRK |
Merck & Co., Inc.
|
85,329 | $10,964,776 | |
| 5 | AMGN |
Amgen Inc
|
23,056 | $8,349,037 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
24,740 | $3,125,651 | |
| 7 | PFE |
Pfizer Inc
|
101,513 | $2,444,433 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
36,383 | $2,096,388 |
All Filings in JNJ
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $65,848,324 | 259,276 | Shares | Defined | 2026-07-24 | |
| 2026-03-31 | $88,693,342 | 362,843 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $79,889,736 | 386,034 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $81,288,498 | 438,402 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $69,153,438 | 452,723 | Shares | Defined | 2025-07-25 | |
| 2025-03-31 | $67,225,565 | 405,364 | Shares | Defined | 2025-04-11 | |
| 2024-12-31 | $52,952,178 | 366,147 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $53,883,167 | 332,489 | Shares | Sole | 2024-10-18 | |
| 2024-06-30 | $46,112,456 | 315,493 | Shares | Defined | 2024-08-08 | |
| 2024-03-31 | $39,552,085 | 250,029 | Shares | Defined | 2024-04-30 | |
| 2023-12-31 | $27,780,910 | 177,242 | Shares | Sole | 2024-01-11 | |
| 2023-09-30 | $19,274,685 | 123,754 | Shares | Sole | 2023-10-30 | |
| 2023-06-30 | $12,275,956 | 74,166 | Shares | Defined | 2023-07-28 | |
| 2023-03-31 | $9,325,265 | 60,163 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $9,824,036 | 55,613 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $8,617,565 | 52,752 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $9,228,211 | 51,987 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $9,140,459 | 51,574 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $7,104,878 | 41,532 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $4,942,545 | 30,604 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $4,007,958 | 24,329 | Shares | Defined | 2021-07-16 | |
| 2021-03-31 | $2,530,989 | 15,400 | Shares | Defined | 2021-07-09 | |
| 2020-12-31 | $2,345,748 | 14,905 | Shares | Sole | 2021-02-09 | |
| No filing history on record for this holder in this stock. | ||||||